After being out of commission for several months, the ChargEV chargers at Aeon Mall Shah Alam are now online again. Operated ...

During this roadshow, customers can enjoy a range of engaging activities, along with special promotions and exclusive deals ...

Obesity candidate Maritide (maridebart cafraglutide) took center stage during Amgen Inc.’s first-quarter earnings call after market close May 2, with company executives touting early phase II data and ...

Preliminary results of AEON Biopharma's Phase 2 trial for chronic migraine treatment reveal no significant improvement over placebo. Despite anticipated reductions in monthly migraine days, ...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining 2% on Friday. The Dow traded up 1.16% to 38,670.87 while the NASDAQ rose 2% to 16,157.26. The S&P 500 also rose, ...

U.S. stock index futures on Friday surged, after the latest nonfarm payrolls report came in much cooler than expected and ...

Healthcare Triangle (HCTI) +23%. ModivCare (MODV) +21%. Alignment Healthcare (ALHC) +20%. Losers: AEON Biopharma (AEON) -54%.

By Colin Kellaher AEON Biopharma shares lost more than half of their value and hit a new all-time low after the clinical-stage biopharmaceutical ...

AEON Bio­phar­ma said its bot­u­linum tox­in treat­ment can­di­date failed a Phase 2 mi­graine study at the planned in­ter­im analy­sis. The com­pa­ny ...

Wrath: Aeon of Ruin is a proper throw back to the early days of first-person shooters – so much so, it’s based on the tech that powered one of the first games I eveR played in the genre, Quake. It’s ...

Retail sales and services revenue in the first four months of this year totaled 2.06 quadrillion VND (81.06 billion VND), up ...

IRVINE, Calif., May 03, 2024 (GLOBE NEWSWIRE) --, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex ...